Answers are grounded in this paper and cite their sources.
Background: Recent reports show that approximately 939 million individuals globally have experienced Hepatitis E virus infection, and 15 to 110 million have recent or ongoing HEV infection. This study aimed to evaluate the seroprevalence of Hepatitis E virus infection among pregnant women in Abeokuta, Ogun State. Methods: Blood samples were collected from a cross-section of 230 consenting healthy pregnant women with no history of immuno-suppressive diseases attending Oba-Ademola Maternity Hospital, Abeokuta, Nigeria. A structured questionnaire was administered to participants containing sociodemographic information such as age, education, marital status, occupation, parity, and pregnancy trimester. Collected plasma was subjected to the analysis of Hepatitis E Immunoglobulin G (IgG) and M (IgM) using an Enzyme-Linked Immunosorbent Assay (ELISA) kit. Data were subjected to statistical analysis using SPSS version 20.0. Results: Seroprevalence for anti-HEV IgG and anti-HEV IgM were 7.8% and 4.3% respectively. Seroprevalence of age group 15-19 years was 33.3% for HEVIgM and 0.0% for HEVIgG, 20-24 years was 7.5% for HEVIgG and 2.5% for HEVIgM, 25-29 years was 3.8% and 2.6% for both HEVIgG and IgM respectively. Ages 30-34 was 5.8% for both HEV IgG and IgM while ages 35-<40 was 57.3% for anti-HEV IgG and 6.5% for HEV IgM. Based on education status, those with primary education were 15.0% for HEV IgG and 10.0 for HEV IgM, secondary education was 9.3% for HEV IgG and 4.1% for HEV IgM and tertiary education was 5.3%, and 3.5% for both HEV IgG and IgM. With regards to trimester, in those in their first trimester, 18.5% seroprevalence was recorded for HEV IgG and 11.1% for HEV IgM, second trimester 8.3% for HEV IgG and 6.4% for HEV IgM, also for third trimester 4.3% for HEV IgG, however, no prevalence was recorded for anti-HEV IgM. This study shows a high rate of seroprevalence observed for both anti-HEV IgG and IgM in pregnant women who were in their first trimester. Conclusion: This study reveals that a significant number of cases in the study area have had exposure to HEVin their life time.
No takes yet. Share an insight, caveat, or question.
Williams Ibangha Ike (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: